Park Avenue Securities’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Buy |
+1,999
| New | +$303K | ﹤0.01% | 1279 |
|
|
2025
Q1 | – | Sell |
-2,785
| Closed | -$514K | – | 1238 |
|
|
2024
Q4 | $514K | Sell |
2,785
-559
| -17% | -$103K | 0.01% | 1060 |
|
|
2024
Q3 | $659K | Sell |
3,344
-557
| -14% | -$110K | 0.01% | 864 |
|
|
2024
Q2 | $806K | Buy |
3,901
+86
| +2% | +$17.8K | 0.01% | 765 |
|
|
2024
Q1 | $1.03M | Buy |
3,815
+203
| +6% | +$55K | 0.01% | 648 |
|
|
2023
Q4 | $854K | Sell |
3,612
-446
| -11% | -$105K | 0.01% | 688 |
|
|
2023
Q3 | $795K | Buy |
+4,058
| New | +$795K | 0.01% | 656 |
|
|
2023
Q1 | – | Sell |
-3,825
| Closed | -$833K | – | 794 |
|
|
2022
Q4 | $833K | Buy |
3,825
+277
| +8% | +$60.3K | 0.01% | 604 |
|
|
2022
Q3 | $698K | Sell |
3,548
-4,775
| -57% | -$939K | 0.01% | 602 |
|
|
2022
Q2 | $1.78M | Sell |
8,323
-231
| -3% | -$49.4K | 0.03% | 294 |
|
|
2022
Q1 | $2.43M | Buy |
8,554
+1,916
| +29% | +$544K | 0.04% | 237 |
|
|
2021
Q4 | $2.5M | Buy |
6,638
+394
| +6% | +$148K | 0.04% | 241 |
|
|
2021
Q3 | $2.58M | Buy |
6,244
+27
| +0.4% | +$11.1K | 0.05% | 197 |
|
|
2021
Q2 | $2.3M | Buy |
6,217
+442
| +8% | +$164K | 0.05% | 203 |
|
|
2021
Q1 | $1.67M | Buy |
5,775
+556
| +11% | +$161K | 0.04% | 231 |
|
|
2020
Q4 | $1.3M | Buy |
5,219
+141
| +3% | +$35.2K | 0.04% | 234 |
|
|
2020
Q3 | $1.15M | Buy |
5,078
+504
| +11% | +$114K | 0.04% | 214 |
|
|
2020
Q2 | $797K | Buy |
+4,574
| New | +$797K | 0.03% | 235 |
|
|
2020
Q1 | – | Sell |
-4,936
| Closed | -$754K | – | 349 |
|
|
2019
Q4 | $754K | Buy |
4,936
+283
| +6% | +$43.2K | 0.03% | 223 |
|
|
2019
Q3 | $616K | Buy |
+4,653
| New | +$616K | 0.03% | 215 |
|